Lymphoma

Disease State Hub

Featured

Video
Video
08/13/2024
In this video, Hector R. Villarraga, MD, discusses the long-term incidence of heart failure in patients with breast cancer or lymphoma treated with anthracycline therapy and the clinical impact of his...
08/13/2024
FDA Alert
FDA Alert
04/22/2024

Anthony Calabro, MA

Anthony Calabro, MA
The FDA previously approved lisocabtagene maraleucel as a second-line treatment option for adult patients with large B-cell lymphoma in June 2022.
04/22/2024
Video
Video
04/08/2024
Diana Abbott, PhD; Grace Bosma, MS
In this video, Diana Abbott, PhD, and Grace Bosma, MS, discuss their team’s study on the outcomes and intensity of first-line therapy for the treatment of diffuse large B-cell lymphoma (DLBCL) in elderly...
04/08/2024

Clinical Insights

Video
Video
08/13/2024
In this video, Hector R. Villarraga, MD, discusses the long-term incidence of heart failure in patients with breast cancer or lymphoma treated with anthracycline therapy and the clinical impact of his...
08/13/2024
Video
Video
04/08/2024
Diana Abbott, PhD; Grace Bosma, MS
In this video, Diana Abbott, PhD, and Grace Bosma, MS, discuss their team’s study on the outcomes and intensity of first-line therapy for the treatment of diffuse large B-cell lymphoma (DLBCL) in elderly...
04/08/2024
Conference Coverage
Conference Coverage
02/20/2024
Mark Roschewski, MD
In this video, Mark Roschewski, MD, discusses the results of his team’s study of the use of PET/CT scans to assess remission status in patients with aggressive B-cell lymphoma. Dr Roschewski presented these...
02/20/2024
Conference Coverage
Conference Coverage
01/22/2024
Mark Roschewski, MD
In this video, Mark Roschewski, MD, discusses the key points from his team’s research that investigated the value of circulating tumor DNA when treating patients with diffuse large B-cell lymphoma. The...
01/22/2024
Video
Video
09/27/2023
Paolo Strati, MD
In this video, Paolo Strati, MD, discusses chemotherapy-free approaches in the treatment of patients with indolent b-cell lymphoma, including early trials that are underway on the combination of...
09/27/2023